• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Immunosuppressive drugs may pose threat in transplant patients

Article

Washington - Dermatologists should be aware that a number of the treatments they prescribe are associated with an increased risk of skin cancer, said Mark Lebwohl, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Article
Is Your Texting as Caring as Your Bedside Manner?

Is Your Texting as Caring as Your Bedside Manner?

Article
© 2024 MJH Life Sciences

All rights reserved.